Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses

Frontiers in Immunology(2023)10.3389/fimmu.2023.1182504Source: DataRank Database

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.50)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Maria Mader,Hendrik Karsten ORCID,Leon Cords ORCID,Maximilian Knapp ORCID,Sophia Schulte

Live enrichment

PubMed:37215095 PMC:PMC10196118 OpenAlex:https://openalex.org/W4377564151

National Institutes of Health

Grant: P01 AI168347

NIAID NIH HHS

Grant: 75N93019C00065

National Institutes of Health

Grant: 1P01AI168347-01

The Development and Evaluation of Pan-Coronavirus Vaccines

Deutsche Forschungsgemeinschaft

Grant: 80750187/SFB 841

Liver inflammation: infection, immune regulation and consequences

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

European Commission

Grant: 681032

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

Deutsches Zentrum für Infektionsforschung

Deutsche Forschungsgemeinschaft

FWCI

1.50

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2023.1182504

publisherhttps://doi.org/10.3389/fimmu.2023.1182504

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1182504/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37215095

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10196118

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0301 basic medicine0303 health sciences03 medical and health sciencesHumansCD4-Positive T-LymphocytesCommon ColdCOVID-19PeptidesSARS-CoV-2T-LymphocytesCoronavirus RNA-Dependent RNA Polymerase

MeSH Terms

COVID-19SARS-CoV-2Coronavirus RNA-Dependent RNA PolymeraseCommon ColdHumansPeptidesT-LymphocytesCD4-Positive T-Lymphocytes

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakCoronavirusCommon coldCoronavirus InfectionsBiologyCross-reactivityBetacoronavirusMedicineCross reactionsGeneticsImmunologyOutbreakAntigenCd4+ T-cellsEpitope AnalysisRna-dependant Rna PolymeraseNsp12Sars-cov-2Sequence IdentitiesCommon Cold CoronavirusesCross-ReactivitiesCD4-Positive T-LymphocytesCoronavirus RNA-Dependent RNA PolymeraseT-LymphocytesCOVID-19RC581-607HumansImmunologic diseases. AllergyPeptides

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses

FAIR Checklist

Authors (18)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)